SRPT Snapshot
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Market Capitalization$6,223,946,000
Price to Sales8.13
Earnings per Share$-4.2850
PE RatioNone
Most Recent Close$71.6100
52 Week High$101.24
52 Week Low$61.28
50-Day Moving Average$76.54
200-Day Moving Average$80.25
All data are from Alpha Vantage as of today. For more infomation on SRPT see Stock Dividend, Valuation, Price and Financial Data for Investors